OTC · OPGN
OpGen, Inc.
$23.91+$9.75 (+64.36%)
OpGen, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.68% below the high.
Loading market information…
OTC · BLMH · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Blum Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Blum Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Blum Holdings, Inc. is an entity operating within California's regulated cannabis market, comprehensively addressing both medical and adult-use demands. The company's multifaceted involvement encompasses the cultivation, production, distribution, and retail sales of cannabis products. Its business activities are organized into two primary divisions: Cannabis Retail and Cannabis Distribution. This includes direct oversight of its cultivation sites, manufacturing facilities, and dispensaries catering to diverse customer needs. The company, originally established in 2010, maintains its principal office in Santa Ana, California. It adopted the name Blum Holdings, Inc. in January 2024, having previously operated as Unrivaled Brands, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$23.91+$9.75 (+64.36%)
OpGen, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.68% below the high.
CA$4.40+CA$0.10 (+2.33%)
Medicure Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.11% below the high.
$0.95-$0.05 (-5.0%)
Eagle Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.45% below the high.
$0.02-$0.00 (-5.56%)
Rhelion Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 60.47% below the high.
$0.00+$0.00 (+5.56%)
Univec, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.22% below the high.
CA$0.03CA$0.00 (0.0%)
Christina Lake Cannabis Corp.’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
$0.05-$0.01 (-14.55%)
Eco-Growth Strategies Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.09% below the high.
CA$0.02CA$0.00 (0.0%)
Nextleaf Solutions Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.43% below the high.
